about
Pushing the envelope in the mTOR pathway: the second generation of inhibitorsMulticenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancerUrinary PGE-M in colorectal cancer: predicting more than risk?Microsatellite instability in colorectal cancer-the stable evidence.Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypesCharacterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.Association between KRAS mutation and lung metastasis in advanced colorectal cancer.MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancersGene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway.The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy.Molecular biology of testicular germ cell tumors.New drug development in digestive neuroendocrine tumors.Molecular dissection of microsatellite instable colorectal cancerMicrosatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines.Genomic Landscape of Colorectal Mucosa and Adenomas.High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal CancerPatient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference.Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).Establishing a diagnostic road map for MUTYH-associated polyposis.Molecular predictors of response to chemotherapy in colorectal cancer.Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis.DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains.Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency.Micromanaging the classification of colon cancer: the role of the microRNAome.Classifying MMR variants: time for revised nomenclature in Lynch syndrome.Multistage vector delivery of sulindac and silymarin for prevention of colon cancer.Cancer: Pinprick diagnostics.High prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic CancerA phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumorsLack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine TumorsBRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumorsUtility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.Reply to L.B. SaltzAcetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain InhibitionMismatch Repair-Proficient Colorectal Cancer: Finding the Right TiME to RespondImmune Activation in Mismatch Repair-Deficient Carcinogenesis: More Than Just Mutational RateRelative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
P50
Q24622222-D7FD1FFE-50A2-480E-BCAF-FFE67CC7A5E5Q33813216-52CF1174-5DC0-4901-B488-85C63DF2414CQ34249997-4CD370A1-215A-4FA8-B4E4-2338E71DAF67Q34289285-1EB4CDF5-0290-47E2-A28D-AE61BC27FC10Q34616565-28BE492D-3A5F-438D-AA8B-404E5C3025E5Q34785026-EBAC9B53-6665-43E9-8741-C197B88CDEDDQ35124790-EA30D651-E608-4B7E-8EE5-9EC483016559Q35218647-B62248CD-E1FD-4475-967C-9331D1E28A31Q35677827-BA205CB8-E22D-4C20-9BA5-B87D2CA1936BQ36123830-D30AD607-00F5-411F-99AD-7EF8DB77A84EQ36182284-DF288F1D-E2D3-490E-942F-A7EA8D92E74FQ36612623-71E888C6-BDDD-4AC8-A6A6-D73382843060Q36684449-0D45ABE0-ED7C-4581-A47E-3405924F852CQ36735939-9B65AE5C-F897-4FEA-896B-1D2E2C5E464FQ36836733-99086F62-1095-4EEE-B742-8BFFAA60EA72Q36977601-FFDBD816-5E66-428F-882A-34A28E299A9EQ37087002-7D655DE9-BEA2-4EE4-B4E8-0EF54F418DE2Q37163874-793C552A-5567-4FC0-8DA5-C519E445860DQ37579711-63DE11E4-8D36-4CF2-A35F-B88FF489BC9CQ37688704-AE1E5A52-F3E6-480F-85E3-1B803673BE48Q37718406-CC8FB03C-B96C-4310-B391-015042CE57D9Q37856121-9740A1D8-A406-4C37-9F57-387D6C7891FCQ38096698-B0457D74-343B-4FF3-8A22-8C1ECE9240AFQ41024077-72BAFA38-0406-4FD3-BA43-A886762FACF2Q41165285-C3EF2573-E4B2-4FBE-8CB2-9D08E18153C4Q41641872-0B25CC21-6C1F-4B2A-BC77-6451DA7FA81CQ42281581-B247051C-0345-4435-A52F-3A13046C0D42Q42837936-5087C9D7-FF40-417F-B85F-6490092653F4Q50552302-A2484F55-4FD2-4711-9957-45ACBEBADE66Q54501368-24A031A7-87CA-428D-824D-9F1E34E65C59Q57053298-11E4DE65-2D94-4D5E-81B7-4438605B4397Q58614520-70DFFED8-F6F4-4B15-A77B-7A41220FB37EQ58614929-5224BE32-6C27-41B0-A06E-C5681D55ABA4Q59274364-3B4787C7-CBD0-436A-8A3E-2E5697100AB2Q64902197-710E7E0F-C5AB-4F02-BD77-4EB8782EFB95Q87392316-9890E626-DA83-4282-B0E4-B91E2FD03375Q91044752-CC09FB97-AFF1-4CEA-A219-1BDA99614143Q91528155-DAC628B8-093C-449A-B059-FE1FBCF1109FQ92430718-2B3D3DA2-3C43-4D98-AFBA-5899D7D69761Q95600726-217796DB-095B-479B-B427-3C0BE4FBDFA8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eduardo Vilar
@ast
Eduardo Vilar
@en
Eduardo Vilar
@es
Eduardo Vilar
@nl
Eduardo Vilar
@sl
type
label
Eduardo Vilar
@ast
Eduardo Vilar
@en
Eduardo Vilar
@es
Eduardo Vilar
@nl
Eduardo Vilar
@sl
prefLabel
Eduardo Vilar
@ast
Eduardo Vilar
@en
Eduardo Vilar
@es
Eduardo Vilar
@nl
Eduardo Vilar
@sl
P106
P1153
8702260400
P21
P31
P496
0000-0001-6404-3761